| 1 |
|
Nanostructured lipid carrier system for topical delivery of terbinafine hydrochloride |
Bulletin of Faculty of Pharmacy, Cairo University |
53 |
2 |
147-159 |
2015 |
Elsevier |
| 2 |
|
Tacrolimus-loaded nanostructured lipid carriers for oral deliveryâOptimization of production and characterization |
European Journal of Pharmaceutics and Biopharmaceutics |
108 |
|
277-288 |
2016 |
Elsevier |
| 3 |
|
3D printing methods for pharmaceutical manufacturing: opportunity and challenges |
Current pharmaceutical design |
24 |
42 |
4949-4956 |
2018 |
Bentham Science Publishers |
| 4 |
|
Nanostructured lipid carriers: An emerging platform for improving oral bioavailability of lipophilic drugs |
International journal of pharmaceutical investigation |
5 |
4 |
182 |
2015 |
|
| 5 |
|
Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation |
Drug development and industrial pharmacy |
42 |
2 |
209-220 |
2016 |
Taylor & Francis |
| 6 |
|
Role of Pâglycoprotein inhibitors in the bioavailability enhancement of solid dispersion of Darunavir |
BioMed Research International |
2017 |
1 |
8274927 |
2017 |
Hindawi |
| 7 |
|
Tacrolimus-loaded nanostructured lipid carriers for oral delivery-in vivo bioavailability enhancement |
European Journal of Pharmaceutics and Biopharmaceutics |
109 |
|
149-157 |
2016 |
Elsevier |
| 8 |
|
Nanocarriers as treatment modalities for hypertension |
Drug delivery |
24 |
1 |
358-369 |
2017 |
Taylor & Francis |
| 9 |
|
Nanostructured lipid carrier in photodynamic therapy for the treatment of basal-cell carcinoma |
Drug delivery |
23 |
4 |
1476-1485 |
2016 |
Taylor & Francis |
| 10 |
|
Optimization of rivastigmine nanoemulsion for enhanced brain delivery: In-vivo and toxicity evaluation |
Journal of molecular liquids |
255 |
|
384-396 |
2018 |
Elsevier |
| 11 |
|
Adaptation of quality by design-based development of isradipine nanostructuredâlipid carrier and its evaluation for in vitro gut permeation and in vivo solubilization fate |
Journal of pharmaceutical sciences |
107 |
11 |
2914-2926 |
2018 |
Elsevier |
| 12 |
|
Riluzole-loaded nanoparticles to alleviate the symptoms of neurological disorders by attenuating oxidative stress |
Drug development and industrial pharmacy |
46 |
3 |
471-483 |
2020 |
Taylor & Francis |
